Publications

We interviewed Dr. Alexis LaPietra, DO, FACEP, the System Director of Addiction Medicine at the RWJBH System and Medical Director for RWJBH’s Institute for Prevention and Recovery (IFPR). We spoke with Dr. LaPietra about RWJBH’s initiatives, and the whys and hows of improving care for New Jerseyans with opioid use disorder (OUD).

Our New Jersey State Policy Lab pilot project to examine facilitators and barriers to buprenorphine use in New Jersey’s emergency departments (EDs) for patients presenting with opioid use disorder (OUD) is a timely contribution to the research on this emerging and important topic.

As the crisis of opioid use disorder (OUD) spread throughout the United States, the health care system took action to develop new treatments and approaches to treating people with OUD.